Clinical Trial Update: Role of Intraoperative Beta Blocker for Morbid Obese Patients Undergoing Laparoscopic Bariatric Surgery [Phase 4]

View source ↗

Summary

Phase 4 clinical trial update examining the role of intraoperative beta blockers in morbidly obese patients undergoing laparoscopic bariatric surgery.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Intraoperative Awareness
• Morbid Obesity
• Postoperative Pain

Snippet

Sponsor: Ain Shams University | Conditions: Intraoperative Awareness, Postoperative Pain | Phase 4 | Status: UNKNOWN